However, this customization can also lead to inconsistencies in the active ingredients, which is a significant concern for patient safety
Risks: Possible side effects like allergic reactions, nausea, or injection site discomfort
This test enhances treatment selection but does not determine basic eligibility criteria
In this case, the mechanistic argument has quantitative animal-model support, though human RCT data for the combination remain absent
Symptoms suggestive of pancreatitissevere, persistent abdominal pain radiating to the back, often accompanied by vomitingrequire immediate medical attention, as acute pancreatitis is a rare but serious potential adverse effect of GLP-1 receptor agonists
sglt-2_inhibitors SGLT-2 Inhibitors Canagliflozin (Invokana ) Trade Names: Invokana Drug Class: Anti-diabetic drug, Hypoglycemic, SGLT-2 inhibitor Mechanism of Action: Inhibits the Na-glucose co-transporter 2 (SGLT-2) in the kidney to reduce glucose reabsorption, resulting in increased urinary glucose excretion, and lower plasma glucose